Gunne L M, Andersson U, Bondesson U, Johansson P
Pharmacol Biochem Behav. 1986 Oct;25(4):897-901. doi: 10.1016/0091-3057(86)90404-1.
Single intraperitoneal doses of various antipsychotic drugs (clozapine 6, 12, 25 mg/kg, sulpiride 100 mg/kg, haloperidol 0.5, 1.0, 2.0 mg/kg, fluphenazine 0.5, 1.0, 2.0 mg/kg) induced a depression of the spontaneous chewing movement (SCM) rate in rats during the first 6-8 hours. Haloperidol and fluphenazine elicited a rebound increase in SCM on day 2-5, while clozapine and sulpiride did not. Atropine (5 mg/kg) reduced the SCM rate. During chronic administration for 10 months clozapine (50 mg/kg/day) caused no changes in the SCM rate. Sulpiride (120 mg/kg/day) gave a marginal rise above control levels, while thioridazine (40 mg/kg/day), chlorpromazine (30 mg/kg/day), fluphenazine (0.6 mg/kg/day) and haloperidol (0.4 mg/kg/day) produced highly significant increases in SCM rates. It is suggested that the present animal model may prove useful for monitoring the risk of tardive dyskinesia with individual drugs.
单次腹腔注射不同抗精神病药物(氯氮平6、12、25毫克/千克,舒必利100毫克/千克,氟哌啶醇0.5、1.0、2.0毫克/千克,氟奋乃静0.5、1.0、2.0毫克/千克)可在最初6 - 8小时内使大鼠的自发咀嚼运动(SCM)速率降低。氟哌啶醇和氟奋乃静在第2 - 5天引起SCM的反弹增加,而氯氮平和舒必利则没有。阿托品(5毫克/千克)降低了SCM速率。在10个月的慢性给药期间,氯氮平(50毫克/千克/天)未引起SCM速率变化。舒必利(120毫克/千克/天)使SCM速率略高于对照水平,而硫利达嗪(40毫克/千克/天)、氯丙嗪(30毫克/千克/天)、氟奋乃静(0.6毫克/千克/天)和氟哌啶醇(0.4毫克/千克/天)使SCM速率显著升高。提示该动物模型可能有助于监测个体药物迟发性运动障碍的风险。